General Catalyst

General Catalyst is a venture capital firm established in 2000, headquartered in Cambridge, Massachusetts, with additional offices in North America and Europe. The company specializes in early-stage and growth equity investments, focusing on technology-driven businesses. It invests across various sectors, including consumer internet, enterprise software, fintech, health assurance, and crypto. General Catalyst provides not only capital but also mentorship and resources to accelerate the growth of its portfolio companies. To date, it has managed eight venture capital funds, totaling approximately $3.75 billion in capital commitments.

Adrian Abeijon

Investor

Mark Allen

CFO

Neeraj Arora

Managing Director, Investment Team

Juliet Bailin

Partner

Marc Bhargava

Managing Director

Chris Bischoff

Managing Director

Larry Bohn

Managing Director

Teresa Carlson

President, General Catalyst Institute

Kenneth Chenault

Managing Director and Chairman

Quentin Clark

Managing Director

Mark Crane

Partner, Investment Team

Christopher Davis

Partner, Investments

Kyle Doherty

Managing Director, Investments

Molly Blaauw Gillis

Partner and Chief of Staff

Mina Hsiang

Associate

Nmachi Jidenma

Partner

Christopher Kauffman

Principal and Member of the Investment Team

Genevieve Kinney

Principal

Zak Kukoff

Principal

Paul Kwan

Managing Director

Roy Mabrey

Partner, Investment Team

Holly Maloney McConnell

Managing Director

Karanveer Mohan

Managing Director, Investment Team

Deep Nishar

Managing Director and Member of the Management Committee

Dipchand Nishar

Managing Director

Reva Nohria

Principal

Trevor Oelschig

Managing Director

Tyler Olkowski

Investor

Pranay Orugunta

Healthcare Investor

Mo Punjwani

Associate, Investments

Candace Richardson

Principal

Brian Ru

Principal

Pranav Singhvi

Managing Director

Bill Skarinka

Associate

Hemant Taneja

CEO and Managing Director

Alex Tran

Managing Director, Investments

Catherine Tu

Partner, Investment Team

Elena Viboch

Partner

Andrea Wang

Principal, Early Stage Investment

Nathaniel Levy-Westhead

Partner, Investment Team

Past deals in Healthcare

RISA Labs

Seed Round in 2025
RISA Labs utilizes Multi-Agent Systems to reimagine healthcare, enhancing efficiency and elevating patient care. The company's MAS interface sparks innovation in healthcare, aiming to make healthcare administration more intelligent, responsive, and centered around patients.

Thatch

Series B in 2025
Thatch is a health benefits platform designed to help businesses manage employee healthcare effectively. It offers a suite of tools, including ThatchBot, an AI-powered service that assists employees with healthcare inquiries and expense management. Thatch enables companies to create customized healthcare budgets that cater to the specific needs of individual employees. By providing a unified interface for healthcare spending and saving, Thatch facilitates personalized healthcare experiences, allowing employees to navigate their benefits with ease and efficiency.

Stance Health

Pre Seed Round in 2025
Stance Health is a health technology company specializing in musculoskeletal (MSK) care. It develops a health and wellness platform that integrates medical science and technology to deliver evidence-based orthopedic rehabilitation. The company focuses on performance recovery and prevention, offering personalized programs for individuals with MSK conditions. Services include advanced diagnostic tools, tailored rehabilitation plans, and ongoing assessments, helping patients recover, prevent injuries, and improve their overall physical well-being.

Sohar Health

Seed Round in 2025
Sohar Health is a technology company that specializes in behavioral health solutions. It provides an API-based platform designed to streamline eligibility verification and utilize AI-powered medical coding to automate manual workflows. This automation helps to increase patient intake and generate more revenue for healthcare providers. The platform offers tools for secure file management, utilization analytics, and reporting, enabling digital health providers to scale their operations efficiently.

Taxo

Seed Round in 2025
Taxo is a technology company specializing in healthcare administration. It employs proprietary AI models to automate various administrative processes, including retrieving clinical guidelines, verifying insurance coverage, and managing patient records. The company's platform adheres to strict data protection standards, allowing hospitals to concentrate more on patient care.

Arlo Health

Seed Round in 2025
Developer of a health insurance platform designed to provide affordable and employee-centric healthcare coverage. The company offers AI-powered plan management, concierge support, and predictable renewal rates, enabling businesses to control costs, enhance employee satisfaction, and simplify benefits administration.

Eikon Therapeutics

Series D in 2025
Eikon Therapeutics, Inc. is a biopharmaceutical company based in Hayward, California, focused on developing innovative treatments for chronic and life-threatening diseases. Established in 2019, the company employs advanced super-resolution microscopy and live-cell imaging techniques to discover drugs targeting previously intractable proteins. By directly measuring the interactions of chemical compounds with individual proteins within a live cellular environment, Eikon Therapeutics enhances the understanding of biological processes and supports the development of targeted therapies. The integration of biology, engineering, and chemistry in its proprietary platforms allows Eikon Therapeutics to streamline the drug discovery process, advance clinical programs, and expand its pipeline of potential medications.

Fay

Series B in 2025
Fay is a company focused on enhancing individual health through better nutrition by connecting clients with dietitians who are covered by their health insurance. It offers consulting services that specialize in medical nutrition therapy, facilitating access to personalized dietary guidance. Fay assists clients in selecting a suitable dietitian, coordinating both virtual and in-person consultations, and developing tailored nutrition plans. Additionally, the company collaborates with insurance providers to ensure that these services are affordable and accessible, thereby enabling individuals to receive comprehensive nutrition counseling that aligns with their health needs.

Delve

Seed Round in 2025
Delve is a company focused on facilitating HIPAA compliance for its clients through its innovative tracking platform. This platform is designed to streamline the compliance process by automating paperwork and monitoring compliance effectively. Delve's solution includes features that allow for the deployment of work and the integration of continuous integration and continuous deployment (CI/CD) pipelines, enabling infrastructure updates directly from code changes. By simplifying documentation and compliance tracking, Delve helps organizations accelerate their journey to meet regulatory requirements.

Manas AI

Seed Round in 2025
Manas AI uses proprietary AI, generative computational chemistry, and best-in-class biology to reduce the time and expense of traditional medicinal development while also revolutionizing cancer and rare illness treatments.

Neko Health

Series B in 2025
Neko Health is a Swedish health-tech company focused on transforming healthcare through prevention and early detection. The company has developed innovative medical scanning technology that facilitates comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By utilizing advanced sensor technology and artificial intelligence, Neko Health aims to enhance preventive care and reduce the incidence of common diseases, thereby lowering associated healthcare costs. This approach enables healthcare providers to deliver flexible and cost-effective examinations, ultimately improving the quality of care and emphasizing the importance of preventive health measures.

Hippocratic AI

Series B in 2025
Hippocratic AI is a developer of safety-focused large language models designed for non-diagnostic, patient-facing applications within the healthcare sector. The company emphasizes the importance of evidence-based healthcare content, distinguishing itself from typical models that rely on a broader range of internet data, which may include inaccuracies. By prioritizing the acquisition of reliable healthcare information, Hippocratic AI aims to enhance healthcare accessibility and improve health outcomes. Its platform facilitates the delivery of healthcare services, allowing patients to receive care at home and manage their health more effectively and conveniently.

Orange Health Labs

Venture Round in 2024
Orange Health Labs is a health tech startup focused on providing diagnostic laboratory services that facilitate remote healthcare delivery. By enabling doctors to conduct tests and diagnostics from a patient's home, the company aims to enhance the accessibility and efficiency of healthcare. Its patient-centric approach allows individuals to avoid clinic visits for blood tests and other diagnostic procedures by offering affordable home sample collection and timely access to test results. This model not only minimizes the inconvenience of traditional healthcare services but also significantly reduces wait times for critical health assessments, ultimately making healthcare more seamless and responsive to consumer needs.

Soda Health

Series B in 2024
Soda Health, established in 2021 with its headquarters in Chicago, Illinois, is a healthcare technology company focused on reducing health disparities by addressing social determinants of health. The company operates a platform designed to help individuals identify, access, and afford necessary resources for leading healthier lives. This platform facilitates personalized benefit administration and reimbursement, bridging the gap between medical claims and retail payments more cost-effectively than traditional methods.

Endo Health

Seed Round in 2024
Endo Health is a developer of an innovative AI platform aimed at managing type 2 diabetes through gamification. The company’s technology serves as an AI endocrinologist, guiding patients through the various stages of diabetes management. By utilizing continuous glucose monitoring, Endo Health collects real-time data on blood sugar levels and physical activity, allowing diabetic patients to enhance their lifestyle habits effectively. The platform is designed to make the management of chronic diseases more engaging and accessible, transforming the often challenging process into a more enjoyable experience for users.

OASYS NOW

Seed Round in 2024
OASYS NOW is a technology company focused on improving treatment access for chronic patients by efficiently connecting them with relevant clinical trials tailored to their unique health data. Utilizing advanced algorithms, the platform enhances the likelihood of patients finding personalized treatment options on a global scale. OASYS NOW emphasizes patient privacy through a privacy-by-design approach, ensuring that sensitive health data is handled securely and ethically. In addition to its patient-centric services, the company also offers solutions in legal, cybersecurity, and data-sharing, aimed at supporting organizations involved in health and genomics. By leveraging large medical datasets, OASYS NOW strives to enhance health outcomes while maintaining a strong commitment to data security and ethical practices.

Medeloop

Series A in 2024
Medeloop is an innovative platform that utilizes advanced artificial intelligence to enhance medical research processes. By linking, harmonizing, and analyzing vast amounts of health data, Medeloop enables researchers to efficiently develop hypotheses and identify biomarkers for clinical studies, even in areas that are traditionally understudied. The company's technology converts diverse medical data into a graph database, facilitating deeper insights and connections with external resources. Additionally, Medeloop provides a patient-facing application that empowers individuals to manage their health data and contribute to impactful research. This dual approach not only accelerates the clinical research timeline but also encourages public involvement, ultimately aiming to improve treatment development and patient outcomes.

Pharos

Seed Round in 2024
Pharos is a Hospitals and Health Care tech that helps with quality reporting without any manual chart review.

Alpha9 Theranostics

Series C in 2024
Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies. The company is creating a strong pipeline of radiopharmaceuticals to target solid and hematologic malignancies. Its systematic approach to radiotherapeutic design is fueled by a toolbox of technologies and chemistries, which offers broad potential for expansion into a multitude of oncology targets. Alpha9 Theranostics was founded in 2019 and is headquartered in Vancouver, Canada.

HealthEx

Series A in 2024
HealthEx is a healthcare data-sharing platform that aims to revolutionize health data collaboration by fostering a patient-centric ecosystem. The company focuses on creating networks among patients, health systems, and life sciences to facilitate precision medicine. By emphasizing digital rights, patient consent, and audibility, HealthEx is developing the infrastructure necessary for a participatory health data environment. This approach enables clients to engage in patient-mediated data collaboration, ultimately unlocking the potential for improved healthcare outcomes and innovation in medical research.

Primus

Seed Round in 2024
Primus helps elderly people slow the aging process by eliminating loneliness and achieving 'Zero Falls'. We ensure that we are proactive rather than reactive by conducting a series of examinations prior to onboarding elders so that they can be monitored by our in-house medical staff under a personalized care plan.

Astrix Health

Pre Seed Round in 2024
Astrix Health, headquartered in San Francisco with offices in New York City and London, specializes in AI-driven procurement solutions for healthcare providers. The company employs generative AI to analyze vast amounts of data from various sources, delivering actionable pricing insights for medical supplies, equipment, and pharmacy orders. This enables providers to secure better deals from reputable vendors, optimizing their procurement processes. Astrix's team comprises experts from renowned institutions like Palantir, Oxford, Duke Health, and MedStar Health. The company is backed by Y Combinator and operates globally.

Maven Clinic

Series F in 2024
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Taxo

Seed Round in 2024
Taxo is a technology company specializing in healthcare administration. It employs proprietary AI models to automate various administrative processes, including retrieving clinical guidelines, verifying insurance coverage, and managing patient records. The company's platform adheres to strict data protection standards, allowing hospitals to concentrate more on patient care.

Thatch

Series A in 2024
Thatch is a health benefits platform designed to help businesses manage employee healthcare effectively. It offers a suite of tools, including ThatchBot, an AI-powered service that assists employees with healthcare inquiries and expense management. Thatch enables companies to create customized healthcare budgets that cater to the specific needs of individual employees. By providing a unified interface for healthcare spending and saving, Thatch facilitates personalized healthcare experiences, allowing employees to navigate their benefits with ease and efficiency.

Doccla

Series B in 2024
Doccla is a provider of virtual ward services that focuses on shifting patient care from hospitals to home settings. The company partners with care organizations to facilitate early patient discharge and reduce hospital readmissions through remote monitoring using advanced medical devices. By onboarding patients at home with the necessary monitoring equipment, Doccla employs a mobile team of healthcare professionals, including nurses and doctors, to oversee patient care. This approach not only ensures that patients receive timely and effective treatment but also aims to enhance care quality while lowering associated costs. Originally developed as part of a research initiative for the NHS, Doccla's innovative service has been successfully implemented in collaboration with Northampton General Hospital.

Clarium Health

Venture Round in 2024
Clarium Health is a developer of an artificial intelligence-based platform aimed at enhancing healthcare operations. The company's innovative platform automates various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to accurately predict demand, allowing hospitals and healthcare centers to optimize staffing and inventory management. This capability helps prevent shortages and stockouts, reduces supplier lead times, and identifies alternative products when necessary. By empowering healthcare providers with intelligent workflow automation and actionable insights, Clarium Health is transforming the efficiency and effectiveness of healthcare delivery.

MD Ally

Series A in 2024
MD Ally, Inc. is a Philadelphia-based company that specializes in developing a telehealth emergency care platform aimed at addressing non-emergency medical needs within emergency medical services. Founded in 2020, the company enhances communication between public safety practitioners and healthcare providers, allowing for efficient triage of callers with non-life-threatening concerns. By integrating telemedicine into the emergency dispatch process, MD Ally facilitates access to virtual medical and behavioral healthcare professionals, in-network follow-up care, and alternative transportation options. This innovative approach enables patients to receive on-demand telehealth services, reducing reliance on costly emergency services and improving overall healthcare accessibility.

HarmonyCares

Venture Round in 2024
HarmonyCares is a provider of home health care services focused on delivering high-quality medical care directly to clients in their homes. The company offers an integrated, physician-driven model that includes primary and specialty care programs tailored for individuals with multiple chronic conditions, cognitive issues, and psychosocial complications. In addition to primary care, HarmonyCares provides ancillary services such as home health, hospice, palliative care, radiology, and laboratory testing. The rebranding from U.S. Medical Management to HarmonyCares in 2022 reflects the company's commitment to enhancing the care experience for patients, particularly the elderly, by enabling them to receive essential health services in a familiar and comfortable environment.

Adonis

Series B in 2024
Adonis is a healthcare revenue intelligence and automation platform that addresses operational challenges in revenue cycle management (RCM). Many healthcare providers struggle to collect a significant portion of the revenue they are owed, often losing 15% or more due to inefficiencies within traditional RCM systems. Adonis leverages data science and artificial intelligence to streamline processes, automate tasks, detect underpayments, and enhance claim accuracy. By focusing on these critical areas, the platform aims to optimize financial outcomes for medical providers, reducing administrative burdens and allowing them to concentrate on patient care.

Better Health

Series A in 2024
Better Health is a support and supplies platform that focuses on enhancing the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The company provides expert guidance to help patients select and use the appropriate medical supplies for their needs. By delivering peer support and educational resources, Better Health aims to improve patient engagement and adherence, ultimately leading to better health outcomes and reduced healthcare costs. Trusted by various healthcare payers and providers, the company operates in 48 states and has achieved a 98% customer satisfaction rating. Co-founded by Naama Stauber Breckler and Adam Breckler, Better Health is committed to modernizing the medical supplies industry and enhancing the overall patient experience.

Fay

Series A in 2024
Fay is a company focused on enhancing individual health through better nutrition by connecting clients with dietitians who are covered by their health insurance. It offers consulting services that specialize in medical nutrition therapy, facilitating access to personalized dietary guidance. Fay assists clients in selecting a suitable dietitian, coordinating both virtual and in-person consultations, and developing tailored nutrition plans. Additionally, the company collaborates with insurance providers to ensure that these services are affordable and accessible, thereby enabling individuals to receive comprehensive nutrition counseling that aligns with their health needs.

Triomics

Series A in 2024
Triomics is a generative AI-powered platform focused on enhancing oncology research and clinical trial operations. By streamlining processes such as patient recruitment and data collection, the company aims to accelerate trial enrollment and improve quality assurance in healthcare. Its advanced AI technology, which is adept at understanding health records and medical terminology, serves as a foundation for its services. Triomics targets operational inefficiencies common in clinical research, thereby enabling pharmaceutical companies and contract research organizations to conduct more efficient and cost-effective clinical trials. The platform ultimately seeks to enhance the overall effectiveness of oncology care and research.

Blackwell Security

Seed Round in 2024
Blackwell Security offers managed security operations for healthcare organizations to deliver complete protection and rapid response. The company aids in enhancing an organization’s cybersecurity maturity by providing specialized guidance to streamline and bolster its security practices, address gaps in its cyber compliance posture, and proactively facilitate improvements across its program.

Hona AI

Seed Round in 2024
Hona AI is an AI data platform that collects and maintains healthcare history and records of patients.

Transcarent

Series D in 2024
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.

Hippocratic AI

Series A in 2024
Hippocratic AI is a developer of safety-focused large language models designed for non-diagnostic, patient-facing applications within the healthcare sector. The company emphasizes the importance of evidence-based healthcare content, distinguishing itself from typical models that rely on a broader range of internet data, which may include inaccuracies. By prioritizing the acquisition of reliable healthcare information, Hippocratic AI aims to enhance healthcare accessibility and improve health outcomes. Its platform facilitates the delivery of healthcare services, allowing patients to receive care at home and manage their health more effectively and conveniently.

Empathy

Series B in 2024
Empathy is a platform designed to assist families in navigating the complexities of loss. By integrating technology with human support, Empathy offers a digital companion application that empowers bereaved families. The application serves as a comprehensive support system, guiding users through the emotional, financial, legal, and logistical challenges that arise after the death of a loved one. Through its innovative approach, Empathy aims to alleviate some of the burdens faced by families during difficult times.

Chamber Cardio

Seed Round in 2024
Chamber Cardio is a healthcare platform focused on enhancing cardiovascular health services. It aims to transition cardiologists into value-based care by providing a range of services that include panel management, financial metrics, and clinical data integration into a user-friendly dashboard. The platform also offers software support designed to assist healthcare providers in managing complex patient cases effectively. By facilitating value-based contracting, Chamber Cardio ensures that both patients and the healthcare sector receive comprehensive support, ultimately improving treatment accessibility and quality for individuals requiring cardiovascular care.

Finni Health

Series A in 2024
Finni enables passionate ABA providers to start and grow their own in-network practices. We empower providers to go independent in as little as 30 days and offer a complete full-stack solution to run their practice.

Fabric

Series A in 2024
Fabric is a health tech company that enables healthcare providers to deliver faster, higher quality, and more accessible care while reducing costs via consumer-grade patient experiences that automate workflows for staff.

Genial Care

Venture Round in 2024
Genial Care is a company based in São Paulo, Brazil, that specializes in providing care services for children with autism and developmental difficulties. Founded in 2020, it operates a network of physical and digital clinics designed to support the unique needs of autistic children. The company offers real-time monitoring of each child's progress and provides personalized care tailored to individual requirements. In addition to direct care services, Genial Care also focuses on parent training and operates an internal academy dedicated to training therapists. Through these comprehensive services, Genial Care aims to transform the lives of children with autism and empower their families to achieve their full potential.

Summa Health

Acquisition in 2024
Summa Health is a comprehensive healthcare provider that focuses on delivering integrated and coordinated care through a network of hospitals, community health centers, and specialized health services. The organization encompasses a health plan, a physician-hospital organization, and a multi-specialty physician organization, ensuring a wide range of patient care options. Additionally, Summa Health is dedicated to advancing medical knowledge through research and supports various community initiatives via its multiple foundations. Its Cancer Centers are particularly notable, combining advanced treatment technologies and medical expertise with a patient-centered approach to promote holistic healing.

Harbor Health

Series A in 2024
Harbor Health is a multi-specialty clinic group based in Austin, Texas, established in 2022. The company focuses on delivering personalized, patient-centered healthcare by leveraging technology to enhance the health experience. Harbor Health emphasizes a collaborative approach to care, co-creating individualized health paths that align with patients' specific health goals. It offers a range of services, including primary and specialty care, chronic disease management, and behavioral health. The clinic provides convenient access through same-day and virtual appointments, as well as accessible locations, ensuring that patients receive timely and comprehensive care tailored to their needs.

Phare Health

Seed Round in 2023
Phare Health operates an AI platform that automates the extraction of patient care data from unstructured clinical notes, transforming it into structured data for administrative, operational, and financial teams. This enables healthcare systems to enhance resource management, improve cost recovery, and ensure accurate reimbursement, thereby increasing efficiency and resilience in healthcare operations.

Layer Health

Seed Round in 2023
Layer Health is a technology company specializing in AI-driven healthcare information solutions. It develops an AI-powered platform designed to help healthcare providers extract valuable insights from patient data, enabling them to make informed decisions, enhance patient care, and improve operational efficiency. The platform focuses on processing unstructured data from clinical, administrative, and research sources, transforming it into actionable insights.

Commure

Venture Round in 2023
Commure, Inc. is an innovative company that has developed an open platform aimed at healthcare software developers. Founded in 2017 and headquartered in San Francisco, California, with additional offices in Boston, Montreal, and Bogota, Commure provides a comprehensive developer platform that facilitates the creation and deployment of next-generation healthcare applications. This platform is built on the open HL7 FHIR standard, offering essential features such as an FHIR API server, security framework, event service bus, EHR integration, and more. By unifying disparate datasets and delivering meaningful insights, Commure enhances performance and fosters collaboration among doctors, nurses, and patients, ultimately empowering the healthcare ecosystem to improve care delivery. The company's commitment to interoperability and innovation positions it as a leader in the healthcare technology space.

Lottie

Series A in 2023
Lottie is a company focused on transforming the care sector by empowering care seekers through a comprehensive booking platform for care homes. The platform simplifies the search process for families and retirees by providing access to essential resources such as meditation, club booking, outdoor activities, and detailed research on nearby care homes. Additionally, Lottie's platform facilitates digital communication and negotiation of online resident agreements, enhancing the overall experience for users in their quest for suitable care homes and retirement living communities.

Evvy

Series A in 2023
Evvy is a company focused on women's health, specializing in at-home vaginal microbiome tests aimed at closing the gender health gap. By utilizing metagenomic sequencing, Evvy's tests analyze individual symptoms and assess risks related to significant health issues. The company provides personalized reports that empower women with insights into their bodies, facilitating a better understanding of their health and promoting overall well-being.

Cartwheel

Series A in 2023
Cartwheel is a provider of mental health support specifically designed for the school community, founded in 2022 and based in Cambridge, Massachusetts. The company addresses the growing mental health crisis among students by offering evidence-based services from licensed clinicians. Cartwheel partners with schools to facilitate rapid access to mental health assessments, therapy, and medication evaluations, aiming to empower school staff, alleviate family stress, and enhance overall student mental health outcomes. Its program is compliant with FERPA and HIPAA regulations, ensuring it meets the unique needs of educational institutions in the aftermath of the COVID-19 pandemic. By focusing on creating a supportive environment, Cartwheel helps schools become places where every student can thrive.

Medeloop

Seed Round in 2023
Medeloop is an innovative platform that utilizes advanced artificial intelligence to enhance medical research processes. By linking, harmonizing, and analyzing vast amounts of health data, Medeloop enables researchers to efficiently develop hypotheses and identify biomarkers for clinical studies, even in areas that are traditionally understudied. The company's technology converts diverse medical data into a graph database, facilitating deeper insights and connections with external resources. Additionally, Medeloop provides a patient-facing application that empowers individuals to manage their health data and contribute to impactful research. This dual approach not only accelerates the clinical research timeline but also encourages public involvement, ultimately aiming to improve treatment development and patient outcomes.

Georgiamune

Series A in 2023
Georgiamune is a biotechnology company specializing in immunotherapy for cancer treatment. It develops advanced immunotherapeutic and homeostatic therapies aimed at enhancing the body's natural defenses against cancer, with the goal of improving patient recovery times.

Neko Health

Series A in 2023
Neko Health is a Swedish health-tech company focused on transforming healthcare through prevention and early detection. The company has developed innovative medical scanning technology that facilitates comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By utilizing advanced sensor technology and artificial intelligence, Neko Health aims to enhance preventive care and reduce the incidence of common diseases, thereby lowering associated healthcare costs. This approach enables healthcare providers to deliver flexible and cost-effective examinations, ultimately improving the quality of care and emphasizing the importance of preventive health measures.

Berry Health

Pre Seed Round in 2023
Berry Health is a consumer health startup focused on providing remote diagnosis and treatment for chronic medical conditions. The company aims to enhance the lives of individuals dealing with under-served and stigmatized health issues while promoting patient agency. Berry Health offers online private medical consultations, prescription medications, and nationwide delivery services. Its comprehensive approach addresses various health concerns, including dermatology, hair loss, mental health, and sexual health for both men and women. By enabling patients to access effective care remotely, Berry Health seeks to help individuals maintain better overall health, reduce inflammation and pain, optimize immunity, and enhance brain health.

Adonis

Series A in 2023
Adonis is a healthcare revenue intelligence and automation platform that addresses operational challenges in revenue cycle management (RCM). Many healthcare providers struggle to collect a significant portion of the revenue they are owed, often losing 15% or more due to inefficiencies within traditional RCM systems. Adonis leverages data science and artificial intelligence to streamline processes, automate tasks, detect underpayments, and enhance claim accuracy. By focusing on these critical areas, the platform aims to optimize financial outcomes for medical providers, reducing administrative burdens and allowing them to concentrate on patient care.

Hippocratic AI

Seed Round in 2023
Hippocratic AI is a developer of safety-focused large language models designed for non-diagnostic, patient-facing applications within the healthcare sector. The company emphasizes the importance of evidence-based healthcare content, distinguishing itself from typical models that rely on a broader range of internet data, which may include inaccuracies. By prioritizing the acquisition of reliable healthcare information, Hippocratic AI aims to enhance healthcare accessibility and improve health outcomes. Its platform facilitates the delivery of healthcare services, allowing patients to receive care at home and manage their health more effectively and conveniently.

Memora Health

Venture Round in 2023
Memora Health Inc. is a San Francisco-based company founded in 2016 that specializes in enterprise healthcare productivity software aimed at automating outpatient communication. It serves as an intelligent care enablement platform designed to enhance the efficiency of care delivery for clinicians and patients alike. By partnering with health systems, health plans, and digital health companies, Memora Health transforms the care process through the digitization and automation of complex clinical workflows. The platform facilitates proactive engagement by triaging patient-reported concerns to the appropriate care team members, while also providing patients with two-way communication and support throughout their care journeys. This approach allows clinicians to concentrate on their core responsibilities, ultimately improving patient outcomes and the overall healthcare experience.

CTRL Therapeutics

Seed Round in 2023
CTRL Therapeutics is a biotechnology company based in Toronto, Canada, focused on the development of innovative cell therapies. The company has developed a microfluidic platform aimed at optimizing the detection of rare circulating tumor cells, which can be critical in cancer diagnostics. This platform is designed to facilitate the creation of liquid biopsy tests that predict patient responses to targeted therapies. By enabling the evaluation of protein expression on tumor cells, CTRL Therapeutics seeks to enhance the precision of cancer treatment and improve patient outcomes.

Finni Health

Seed Round in 2023
Finni enables passionate ABA providers to start and grow their own in-network practices. We empower providers to go independent in as little as 30 days and offer a complete full-stack solution to run their practice.

MD Ally

Seed Round in 2023
MD Ally, Inc. is a Philadelphia-based company that specializes in developing a telehealth emergency care platform aimed at addressing non-emergency medical needs within emergency medical services. Founded in 2020, the company enhances communication between public safety practitioners and healthcare providers, allowing for efficient triage of callers with non-life-threatening concerns. By integrating telemedicine into the emergency dispatch process, MD Ally facilitates access to virtual medical and behavioral healthcare professionals, in-network follow-up care, and alternative transportation options. This innovative approach enables patients to receive on-demand telehealth services, reducing reliance on costly emergency services and improving overall healthcare accessibility.

Maribel Health

Series A in 2023
Maribel Health is a company focused on developing and operating advanced clinical care models that facilitate home and community-based healthcare. By leveraging innovative healthcare technology, Maribel Health aims to enhance health system capacity and improve patient access to care. The company specializes in assessment and planning services tailored to home and community settings, which support local healthcare markets and strategic needs. Through its initiatives, Maribel Health seeks to transform the delivery of healthcare, ensuring that patients receive the necessary support in their own environments.

Faro Health

Series A in 2023
Faro Health is a developer of a cloud-based medical platform that aims to standardize, automate, and streamline the challenges associated with clinical trials. The company's innovative platform utilizes an integrated clinical development environment, which simplifies the design and authoring processes of complex clinical studies. By leveraging advanced digital protocols, Faro Health provides clinical researchers with in-context, intuitive insights throughout the authoring process. This approach allows researchers to optimize their study designs by reducing the administrative burden of clinical protocols, enabling them to concentrate on the critical decisions that enhance clinical value.

Paradigm

Series A in 2023
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.

Breathe Well-being

Series B in 2023
Breathe Well-being is a health tech startup based in India that focuses on managing and preventing type 2 diabetes through a clinically proven program. The company provides users with personalized support, including one-on-one coaching aimed at tracking weight, meals, and activity, as well as training in cognitive behavioral therapy techniques to reduce stress. Breathe Well-being's platform promotes holistic care for individuals with chronic conditions, enabling them to adopt long-term healthy habits. By fostering community engagement through social interactions and healthy competitions, the company has successfully assisted over 10,000 members in losing weight, lowering blood sugar levels, and mitigating potential health complications.

Genial Care

Grant in 2023
Genial Care is a company based in São Paulo, Brazil, that specializes in providing care services for children with autism and developmental difficulties. Founded in 2020, it operates a network of physical and digital clinics designed to support the unique needs of autistic children. The company offers real-time monitoring of each child's progress and provides personalized care tailored to individual requirements. In addition to direct care services, Genial Care also focuses on parent training and operates an internal academy dedicated to training therapists. Through these comprehensive services, Genial Care aims to transform the lives of children with autism and empower their families to achieve their full potential.

Fay

Seed Round in 2023
Fay is a company focused on enhancing individual health through better nutrition by connecting clients with dietitians who are covered by their health insurance. It offers consulting services that specialize in medical nutrition therapy, facilitating access to personalized dietary guidance. Fay assists clients in selecting a suitable dietitian, coordinating both virtual and in-person consultations, and developing tailored nutrition plans. Additionally, the company collaborates with insurance providers to ensure that these services are affordable and accessible, thereby enabling individuals to receive comprehensive nutrition counseling that aligns with their health needs.

Disclo

Venture Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.

Vial

Series B in 2022
Vial is a biotech company that operates a clinical trial platform designed to reduce costs and barriers in drug development. The platform partners with clinics, transforming them into clinical trial research sites by providing necessary equipment, managing administrative tasks such as patient recruitment, scheduling, data entry, invoicing, and compliance. This enables biotechnology companies to efficiently conduct trials across various phases while allowing partner clinics to increase their revenue.

Vial

Series A in 2022
Vial is a biotech company that operates a clinical trial platform designed to reduce costs and barriers in drug development. The platform partners with clinics, transforming them into clinical trial research sites by providing necessary equipment, managing administrative tasks such as patient recruitment, scheduling, data entry, invoicing, and compliance. This enables biotechnology companies to efficiently conduct trials across various phases while allowing partner clinics to increase their revenue.

Maven Clinic

Series E in 2022
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.

Apiiro

Series B in 2022
Apiiro is a code security startup based in New York, founded in 2019. It provides a software platform called Code Risk Platform designed to help companies identify and address security issues within their applications. The platform analyzes developer behavior and code to detect vulnerabilities such as weak encryption and malware injection points, as well as regulatory compliance violations. By offering complete visibility and actionable insights, Apiiro enables security and development teams to proactively remediate risks before releasing software to the cloud. The company's solutions are used by large enterprises in various sectors including gaming, healthcare, software development, and banking across the United States.

Doccla

Series A in 2022
Doccla is a provider of virtual ward services that focuses on shifting patient care from hospitals to home settings. The company partners with care organizations to facilitate early patient discharge and reduce hospital readmissions through remote monitoring using advanced medical devices. By onboarding patients at home with the necessary monitoring equipment, Doccla employs a mobile team of healthcare professionals, including nurses and doctors, to oversee patient care. This approach not only ensures that patients receive timely and effective treatment but also aims to enhance care quality while lowering associated costs. Originally developed as part of a research initiative for the NHS, Doccla's innovative service has been successfully implemented in collaboration with Northampton General Hospital.

Redesign Health

Series C in 2022
Redesign Health is a company founded in 2018 that focuses on driving innovation in the healthcare sector. It develops technologies, tools, and insights designed to lower barriers to change within the industry. Redesign Health collaborates with exceptional founders to create and support over two dozen companies that have collectively impacted more than ten million lives across various healthcare domains, including cancer care, teleradiology, COVID-19 testing, and metabolic health. By fostering the growth of diverse healthcare solutions, Redesign Health aims to enhance the overall efficiency and effectiveness of healthcare delivery.

Certify

Series A in 2022
CertifyOS is a data intelligence company focused on enhancing the accessibility of provider data within the U.S. healthcare system. Its platform automates the entire provider network management lifecycle through an API-first, user interface agnostic approach. By integrating with numerous primary sources, CertifyOS facilitates near real-time verification and credentialing processes for provider enrollment. This capability positions the company as a comprehensive solution for insurance companies and virtual care providers, allowing them to efficiently manage and scale their provider networks while simplifying tasks such as licensing, monitoring, and sourcing providers.

Plume Clinic

Series B in 2022
Plume is a health tech company for the transgender community. The company focuses on radically increasing access to care, medication, and products for the trans community, supporting a bold, authentic and healthy lifestyle. Its vision is to make gender-affirming care available to anyone until it transforms healthcare for every trans life.

Fractyl Health

Series F in 2022
Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.

Homeward

Series B in 2022
Homeward is a healthcare services provider focused on improving access to quality care for the 60 million Americans living in rural communities. The company employs a multidisciplinary care team that operates both in-home and through mobile care units, utilizing technology for remote monitoring. This approach aims to connect patients with high-quality, affordable care, particularly for Medicare-eligible beneficiaries. Homeward partners with Medicare Advantage plans and assumes full financial risk for the care of its members, with the objective of enhancing health outcomes while reducing costs.

GetSupp

Seed Round in 2022
GetSupp is an AI-driven marketplace focused on health and nutrition, offering users the ability to learn about, discover, and purchase genuine nutritional supplements. The company specializes in helping individuals identify the right supplements for their specific health needs, promoting healthier lifestyles through expert-led guidance tailored to each user. By leveraging artificial intelligence, GetSupp aims to enhance the experience of finding effective health solutions, ensuring that customers receive personalized support that leads to meaningful results.

Lottie

Seed Round in 2022
Lottie is a company focused on transforming the care sector by empowering care seekers through a comprehensive booking platform for care homes. The platform simplifies the search process for families and retirees by providing access to essential resources such as meditation, club booking, outdoor activities, and detailed research on nearby care homes. Additionally, Lottie's platform facilitates digital communication and negotiation of online resident agreements, enhancing the overall experience for users in their quest for suitable care homes and retirement living communities.

August Health

Series A in 2022
August Health is a technology company focused on enhancing the quality of care for older adults living in senior living communities. The company has developed a healthcare platform that collects data to generate insights into the wellness of seniors, facilitating access to both clinical and social support services. By leveraging this technology, August Health aims to empower aging individuals to manage their health more effectively and reduce their annual long-term care expenses. Through its innovative approach, the company addresses the specific needs of vulnerable older adults, contributing to improved healthcare outcomes in this demographic.

Examedi

Series A in 2022
Examedi is a healthcare startup that facilitates at-home medical services by connecting patients with independent healthcare providers, including nurses and lab technicians. The company's telemedicine platform allows patients to book diagnostic tests and examinations from the comfort of their homes, focusing on services such as blood tests, pregnancy tests, general check-ups, and COVID-19 testing. By streamlining the scheduling process and offering affordable access to various medical tests, Examedi aims to enhance patient convenience and improve healthcare delivery.

Flexpa

Seed Round in 2022
Flexpa is a healthcare technology company founded in 2021 and based in San Francisco, California. The company specializes in developing APIs that facilitate the integration of claims histories and diagnostic test data into digital health applications and fintech platforms. By digitizing and interpreting data collected from various hardware providers, Flexpa creates analytics dashboards that help healthcare providers monitor individual and population health outcomes. This enables more informed decision-making regarding treatment plans and pharmaceutical options for patients, ultimately aiming to enhance healthcare delivery and improve patient outcomes.

Sesame

Series B in 2022
Sesame, Inc., operating as SesameCare, is a healthcare technology company founded in 2018 and based in New York, New York. The company has developed an innovative platform that enables users to book medical appointments and access healthcare services conveniently and affordably. By leveraging an AI-enabled marketplace, SesameCare eliminates the need for health insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. This approach allows the company to offer Americans high-quality medical care at significantly reduced costs. Additionally, Sesame is recognized as the official telehealth partner of Costco, further enhancing its reach and service offerings.

Capital Rx

Series C in 2022
Capital Rx, Inc. is a health technology company based in New York that serves as a pharmacy benefit manager, specializing in the administration of self-insured prescription benefit plans for employers, unions, and government entities. Founded in 2017, Capital Rx aims to redefine the pricing and administration of prescriptions in the United States through its innovative Clearinghouse Model, which enhances the transparency of the pharmacy supply chain and reduces costs for employer groups. The company's enterprise platform integrates various components of the pharmacy ecosystem, improving administrative workflows and clinical oversight while facilitating better coordination between patients and healthcare providers. By focusing on actionable strategies that enhance plan performance and patient outcomes, Capital Rx seeks to advance healthcare infrastructure and elevate the standards of clinical care.

CHARM Therapeutics

Series A in 2022
CHARM Therapeutics is a biotechnology company focused on delivering innovative medicines by leveraging advanced 3D deep learning and drug discovery technologies. Its platform is designed to address challenging disease targets that are typically considered undruggable, thereby enhancing treatment options for patients. By utilizing cutting-edge methodologies, CHARM Therapeutics aims to develop therapeutics with transformational efficacy, ultimately assisting healthcare professionals in improving patient outcomes.

Orange Health Labs

Series B in 2022
Orange Health Labs is a health tech startup focused on providing diagnostic laboratory services that facilitate remote healthcare delivery. By enabling doctors to conduct tests and diagnostics from a patient's home, the company aims to enhance the accessibility and efficiency of healthcare. Its patient-centric approach allows individuals to avoid clinic visits for blood tests and other diagnostic procedures by offering affordable home sample collection and timely access to test results. This model not only minimizes the inconvenience of traditional healthcare services but also significantly reduces wait times for critical health assessments, ultimately making healthcare more seamless and responsive to consumer needs.

Mirvie

Series B in 2022
Mirvie is a biotechnology company specializing in non-invasive tests for maternal-fetal health, aimed at enhancing the safety of pregnancy. Founded in 2018 by Maneesh Jain and based in South San Francisco, California, Mirvie provides predictive diagnostic tools that deliver actionable insights to expectant mothers and families. Its medical diagnostic platform enables healthcare practitioners to identify at-risk pregnancies, facilitating timely interventions and therapeutic approaches to improve pregnancy outcomes. Through its innovative solutions, Mirvie seeks to empower families with critical information, ensuring a safer pregnancy experience.

Odyssey Therapeutics

Series B in 2022
Odyssey Therapeutics is a biotechnology company focused on the development of next-generation immunomodulators and oncology medicines. By leveraging an integrated drug-hunting engine, the company aims to enhance the efficiency of drug discovery, unlocking high-potential targets while reducing the risk of attrition during the development process. Odyssey is committed to advancing precision medicine in the healthcare sector, with a product pipeline designed to facilitate a faster transition to clinical development, thereby improving treatment options for patients with various health conditions.

Osmind

Series B in 2022
Osmind Inc. is a San Francisco-based public benefit corporation founded in 2020 that specializes in developing healthcare software tailored for mental health providers and their patients. The company focuses on advancing evidence-based medicine to support individuals suffering from moderate to severe mental health conditions. Osmind's electronic health record platform is designed specifically for clinicians and researchers, facilitating interventional treatment workflows. It includes features such as journaling tools and support for health plan reimbursement, empowering healthcare professionals to implement innovative therapeutic approaches and precision psychiatry. By providing robust technology, Osmind aims to inform best practices in patient care and contribute to the development of new life-saving mental health treatments.

Loop

Series B in 2022
Loop Health is a healthcare provider based in Pune, India, founded in 2018. The company offers a range of services including acute and urgent care, chronic condition management, women's health, health coaching, and preventive care. Loop Health aims to simplify the healthcare experience by connecting patients with family physicians, specialists, and hospitals, facilitating access to major medical treatments. Their team of Loop Coordinators assists patients in finding appropriate doctors, comparing treatment costs, obtaining second opinions, and managing admission procedures, thereby alleviating the stress associated with healthcare decisions. Additionally, Loop Health features a virtual medical practice that supports employees and their families, allowing them to consult with healthcare experts and medical advisors without delay, ultimately promoting better health management and cost-effectiveness.

MD Ally

Seed Round in 2022
MD Ally, Inc. is a Philadelphia-based company that specializes in developing a telehealth emergency care platform aimed at addressing non-emergency medical needs within emergency medical services. Founded in 2020, the company enhances communication between public safety practitioners and healthcare providers, allowing for efficient triage of callers with non-life-threatening concerns. By integrating telemedicine into the emergency dispatch process, MD Ally facilitates access to virtual medical and behavioral healthcare professionals, in-network follow-up care, and alternative transportation options. This innovative approach enables patients to receive on-demand telehealth services, reducing reliance on costly emergency services and improving overall healthcare accessibility.

Alinea Health

Venture Round in 2022
Alinea Health is a health-tech startup that provides solutions for corporate health. It utilizes large amounts of data and proprietary algorithms to assist the client company's beneficiaries in navigating their health plans, providing personalized and unbiased guidance, recommendations from the most effective doctors in the accredited network, and conveniences such as scheduling consultations and exams. In addition to continuous monitoring, its doctors use the Lifestyle Medicine methodology to promote a healthy lifestyle and lower the risk of developing chronic diseases.

Avant-garde Health

Series A in 2022
Avant-garde Health, Inc. is a health care solutions company based in Allston, Massachusetts, founded in 2014. It specializes in developing a web-based analytics platform that assists hospitals and physicians in analyzing and comparing costs and outcomes associated with care delivery. The platform is designed to enhance clinical decision-making by measuring care process costs, comparing treatment-specific data, and leveraging insights from peer institutions to improve healthcare results. Avant-garde Health collaborates with leading healthcare providers focused on enhancing the value of care, aiming to transform health care delivery through actionable insights that facilitate better understanding and improvement of costs and patient outcomes. The company emerged from research at Harvard Business School, emphasizing value-based health care delivery principles.

Homeward

Series A in 2022
Homeward is a healthcare services provider focused on improving access to quality care for the 60 million Americans living in rural communities. The company employs a multidisciplinary care team that operates both in-home and through mobile care units, utilizing technology for remote monitoring. This approach aims to connect patients with high-quality, affordable care, particularly for Medicare-eligible beneficiaries. Homeward partners with Medicare Advantage plans and assumes full financial risk for the care of its members, with the objective of enhancing health outcomes while reducing costs.

Story Health

Series A in 2022
Story Health Corporation is a healthcare technology company founded in 2020 and based in Saratoga, California. The company develops intelligent embedded virtualized clinical care software tools designed to assist healthcare specialists, including neurologists and primary care physicians, in understanding medical situations and making informed clinical decisions. Story Health's platform utilizes data from high-frequency sources to enhance therapy management through virtual protocols and adaptive machine learning. By focusing on patient-centered design, Story Health aims to bridge the gap between clinical evidence and real-world patient experiences, enabling clinicians to effectively address the physiological effects of disease and therapy.

Equip Health

Series B in 2022
Equip is a virtual program helping families recover from eating disorders at home with comprehensive, gold-standard care created by experts in the field and people in recovery. Equip’s five-person care teams include dieticians, physicians, therapists, and mentors who deliver wrap-around support to provide families progress and lasting recovery. Kristina Saffran and Erin Parks co-founded the company in San Diego, California in 2019.

Ro

Venture Round in 2022
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.

Dewpoint Therapeutics

Series C in 2022
Dewpoint Therapeutics, Inc. is a Boston-based biotech company focused on the research and development of biomolecular condensates, aiming to create innovative treatments for a range of diseases, including cancer, neurodegenerative disorders, immunological conditions, cardiovascular issues, women's health, and viral infections. Founded in 2018, the company utilizes a proprietary platform that combines experimental techniques with machine-learning-based image analysis to visualize and study biomolecular condensates. This technology includes a collection of genetically engineered cell lines designed to track condensates and mitigate harmful protein sequestration. By leveraging its advanced capabilities, Dewpoint Therapeutics seeks to address unmet medical needs and enhance drug discovery across multiple therapeutic areas, collaborating with leading academic and pharmaceutical partners to further its mission.

Casana

Series B in 2022
Casana, officially known as Heart Health Intelligence Inc., is a healthcare technology company based in Rochester, New York, founded in 2018. It specializes in developing innovative solutions for heart health monitoring, primarily through its flagship product, the Heart Seat. This smart toilet seat is designed to facilitate effortless and continuous in-home health monitoring by capturing essential clinical measurements such as heart rate, blood pressure, cardiac output, ECG, and blood oxygenation. The Heart Seat integrates advanced sensors, including a single-lead ECG, embedded photoplethysmogram LEDs, and sensitive weight sensors, to monitor cardiac activity. By offering a cloud-connected platform, Casana enables healthcare practitioners to track patients' cardiac health beyond traditional clinical settings, thereby enhancing the management of chronic conditions and improving patient outcomes through reliable and consistent vital signs analysis.

Transcarent

Series C in 2022
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.